nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple Sclerosis
|
Ingwersen, Jens |
|
2015 |
13 |
1 |
p. 47-57 |
artikel |
2 |
Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple Sclerosis
|
Ingwersen, Jens |
|
|
13 |
1 |
p. 47-57 |
artikel |
3 |
Anti-B-Cell Therapies in Autoimmune Neurological Diseases: Rationale and Efficacy Trials
|
Alexopoulos, Harry |
|
2015 |
13 |
1 |
p. 20-33 |
artikel |
4 |
Anti-B-Cell Therapies in Autoimmune Neurological Diseases: Rationale and Efficacy Trials
|
Alexopoulos, Harry |
|
|
13 |
1 |
p. 20-33 |
artikel |
5 |
Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies
|
Gastaldi, Matteo |
|
2015 |
13 |
1 |
p. 147-162 |
artikel |
6 |
Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies
|
Gastaldi, Matteo |
|
|
13 |
1 |
p. 147-162 |
artikel |
7 |
Chronic Treatment with the AMPK Agonist AICAR Prevents Skeletal Muscle Pathology but Fails to Improve Clinical Outcome in a Mouse Model of Severe Spinal Muscular Atrophy
|
Cerveró, Clàudia |
|
2015 |
13 |
1 |
p. 198-216 |
artikel |
8 |
Chronic Treatment with the AMPK Agonist AICAR Prevents Skeletal Muscle Pathology but Fails to Improve Clinical Outcome in a Mouse Model of Severe Spinal Muscular Atrophy
|
Cerveró, Clàudia |
|
|
13 |
1 |
p. 198-216 |
artikel |
9 |
Current Treatment, Emerging Translational Therapies, and New Therapeutic Targets for Autoimmune Myasthenia Gravis
|
Guptill, Jeffrey T. |
|
2015 |
13 |
1 |
p. 118-131 |
artikel |
10 |
Current Treatment, Emerging Translational Therapies, and New Therapeutic Targets for Autoimmune Myasthenia Gravis
|
Guptill, Jeffrey T. |
|
|
13 |
1 |
p. 118-131 |
artikel |
11 |
Efficacy of Intravenous Immunoglobulin in Neurological Diseases
|
Lünemann, Jan D. |
|
2015 |
13 |
1 |
p. 34-46 |
artikel |
12 |
Efficacy of Intravenous Immunoglobulin in Neurological Diseases
|
Lünemann, Jan D. |
|
|
13 |
1 |
p. 34-46 |
artikel |
13 |
Erratum to: Interaction of Paroxetine with Mitochondrial Proteins Mediates Neuroprotection
|
Steiner, Joseph P. |
|
2015 |
13 |
1 |
p. 237 |
artikel |
14 |
Erratum to: Interaction of Paroxetine with Mitochondrial Proteins Mediates Neuroprotection
|
Steiner, Joseph P. |
|
|
13 |
1 |
p. 237 |
artikel |
15 |
Erratum to: Neuronal Glutathione Content and Antioxidant Capacity can be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human Cerebrospinal Fluid
|
Reyes, Reno C. |
|
2015 |
13 |
1 |
p. 239 |
artikel |
16 |
Erratum to: Neuronal Glutathione Content and Antioxidant Capacity can be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human Cerebrospinal Fluid
|
Reyes, Reno C. |
|
|
13 |
1 |
p. 239 |
artikel |
17 |
Erratum to: Remarkable Phenytoin Sensitivity in 4 Children with SCN8A-related Epilepsy: A Molecular Neuropharmacological Approach
|
Boerma, Ragna S. |
|
2015 |
13 |
1 |
p. 238 |
artikel |
18 |
Erratum to: Remarkable Phenytoin Sensitivity in 4 Children with SCN8A-related Epilepsy: A Molecular Neuropharmacological Approach
|
Boerma, Ragna S. |
|
|
13 |
1 |
p. 238 |
artikel |
19 |
Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders
|
Valera, Elvira |
|
2015 |
13 |
1 |
p. 179-189 |
artikel |
20 |
Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders
|
Valera, Elvira |
|
|
13 |
1 |
p. 179-189 |
artikel |
21 |
Immunotherapies for Immune-Mediated Myopathies: A Current Perspective
|
Needham, Merrilee |
|
2015 |
13 |
1 |
p. 132-146 |
artikel |
22 |
Immunotherapies for Immune-Mediated Myopathies: A Current Perspective
|
Needham, Merrilee |
|
|
13 |
1 |
p. 132-146 |
artikel |
23 |
Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity
|
Kampylafka, Eleni I. |
|
2015 |
13 |
1 |
p. 163-178 |
artikel |
24 |
Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity
|
Kampylafka, Eleni I. |
|
|
13 |
1 |
p. 163-178 |
artikel |
25 |
Immunotherapy in Peripheral Neuropathies
|
Léger, Jean-Marc |
|
2015 |
13 |
1 |
p. 96-107 |
artikel |
26 |
Immunotherapy in Peripheral Neuropathies
|
Léger, Jean-Marc |
|
|
13 |
1 |
p. 96-107 |
artikel |
27 |
Immunotherapy Prospects for Painful Small-fiber Sensory Neuropathies and Ganglionopathies
|
Oaklander, Anne Louise |
|
2015 |
13 |
1 |
p. 108-117 |
artikel |
28 |
Immunotherapy Prospects for Painful Small-fiber Sensory Neuropathies and Ganglionopathies
|
Oaklander, Anne Louise |
|
|
13 |
1 |
p. 108-117 |
artikel |
29 |
Improved Treatment Efficacy of Antiangiogenic Therapy when Combined with Picornavirus Vaccination in the GL261 Glioma Model
|
Renner, Danielle N. |
|
2015 |
13 |
1 |
p. 226-236 |
artikel |
30 |
Improved Treatment Efficacy of Antiangiogenic Therapy when Combined with Picornavirus Vaccination in the GL261 Glioma Model
|
Renner, Danielle N. |
|
|
13 |
1 |
p. 226-236 |
artikel |
31 |
Neuro-Immunotherapies: A 30-year Retrospective of an Overwhelming Success and a Brighter Future
|
Dalakas, Marinos C. |
|
2015 |
13 |
1 |
p. 1-3 |
artikel |
32 |
Neuro-Immunotherapies: A 30-year Retrospective of an Overwhelming Success and a Brighter Future
|
Dalakas, Marinos C. |
|
|
13 |
1 |
p. 1-3 |
artikel |
33 |
Neuroimmunotherapies Targeting T Cells: From Pathophysiology to Therapeutic Applications
|
Bittner, Stefan |
|
2015 |
13 |
1 |
p. 4-19 |
artikel |
34 |
Neuroimmunotherapies Targeting T Cells: From Pathophysiology to Therapeutic Applications
|
Bittner, Stefan |
|
|
13 |
1 |
p. 4-19 |
artikel |
35 |
Neuronal Glutathione Content and Antioxidant Capacity can be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human Cerebrospinal Fluid
|
Reyes, Reno C. |
|
2015 |
13 |
1 |
p. 217-225 |
artikel |
36 |
Neuronal Glutathione Content and Antioxidant Capacity can be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human Cerebrospinal Fluid
|
Reyes, Reno C. |
|
|
13 |
1 |
p. 217-225 |
artikel |
37 |
Precision Medicine: SCN8A Encephalopathy Treated with Sodium Channel Blockers
|
Møller, Rikke S. |
|
2015 |
13 |
1 |
p. 190-191 |
artikel |
38 |
Precision Medicine: SCN8A Encephalopathy Treated with Sodium Channel Blockers
|
Møller, Rikke S. |
|
|
13 |
1 |
p. 190-191 |
artikel |
39 |
Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders
|
Kleiter, Ingo |
|
2015 |
13 |
1 |
p. 70-83 |
artikel |
40 |
Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders
|
Kleiter, Ingo |
|
|
13 |
1 |
p. 70-83 |
artikel |
41 |
PROGRAM
|
|
|
2015 |
13 |
1 |
p. 240-260 |
artikel |
42 |
PROGRAM
|
|
|
|
13 |
1 |
p. 240-260 |
artikel |
43 |
Remarkable Phenytoin Sensitivity in 4 Children with SCN8A-related Epilepsy: A Molecular Neuropharmacological Approach
|
Boerma, Ragna S. |
|
2015 |
13 |
1 |
p. 192-197 |
artikel |
44 |
Remarkable Phenytoin Sensitivity in 4 Children with SCN8A-related Epilepsy: A Molecular Neuropharmacological Approach
|
Boerma, Ragna S. |
|
|
13 |
1 |
p. 192-197 |
artikel |
45 |
Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis
|
Shirani, Afsaneh |
|
2015 |
13 |
1 |
p. 58-69 |
artikel |
46 |
Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis
|
Shirani, Afsaneh |
|
|
13 |
1 |
p. 58-69 |
artikel |
47 |
Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis
|
Brenton, J. Nicholas |
|
2015 |
13 |
1 |
p. 84-95 |
artikel |
48 |
Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis
|
Brenton, J. Nicholas |
|
|
13 |
1 |
p. 84-95 |
artikel |